Golfmann, Kristina
Meder, Lydia
Koker, Mirjam
Volz, Caroline
Borchmann, Sven
Tharun, Lars
Dietlein, Felix
Malchers, Florian
Florin, Alexandra
Büttner, Reinhard
Rosen, Neal
Rodrik-Outmezguine, Vanessa
Hallek, Michael
Ullrich, Roland T.
Funding for this research was provided by:
Fritz Thyssen Stiftung (Fritz Thyssen Foundation) (10.16.1.028MN)
Deutsche Forschungsgemeinschaft (German Research Foundation) (UL379/1-1)
Article History
Received: 30 November 2017
Revised: 5 May 2018
Accepted: 30 May 2018
First Online: 3 July 2018
Compliance with ethical standards
:
: RTU received consulting fees from Novartis. FM received consulting fees from NEO NewOncology GmbH. VR-O is now a Novartis employee. The remaining authors declare that they have no conflict of interest.